These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 21464064)
1. Assessment of small bowel function in critical illness: potential role of citrulline metabolism. Peters JH; Beishuizen A; Keur MB; Dobrowolski L; Wierdsma NJ; van Bodegraven AA J Intensive Care Med; 2011; 26(2):105-10. PubMed ID: 21464064 [TBL] [Abstract][Full Text] [Related]
2. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Crenn P; Messing B; Cynober L Clin Nutr; 2008 Jun; 27(3):328-39. PubMed ID: 18440672 [TBL] [Abstract][Full Text] [Related]
3. Enterocyte damage in critically ill patients is associated with shock condition and 28-day mortality. Piton G; Belon F; Cypriani B; Regnard J; Puyraveau M; Manzon C; Navellou JC; Capellier G Crit Care Med; 2013 Sep; 41(9):2169-76. PubMed ID: 23782971 [TBL] [Abstract][Full Text] [Related]
4. The citrulline generation test: proposal for a new enterocyte function test. Peters JH; Wierdsma NJ; Teerlink T; van Leeuwen PA; Mulder CJ; van Bodegraven AA Aliment Pharmacol Ther; 2008 Jun; 27(12):1300-10. PubMed ID: 18331613 [TBL] [Abstract][Full Text] [Related]
5. Plasma citrulline is a marker of absorptive small bowel length in patients with transient enterostomy and acute intestinal failure. Picot D; Garin L; Trivin F; Kossovsky MP; Darmaun D; Thibault R Clin Nutr; 2010 Apr; 29(2):235-42. PubMed ID: 19744750 [TBL] [Abstract][Full Text] [Related]
6. Acute intestinal failure in critically ill patients: is plasma citrulline the right marker? Piton G; Manzon C; Cypriani B; Carbonnel F; Capellier G Intensive Care Med; 2011 Jun; 37(6):911-7. PubMed ID: 21400011 [TBL] [Abstract][Full Text] [Related]
7. [Plasma citrulline concentration--a reliable noninvasive marker of functional enterocyte mass]. Oliverius M; Kudla M; Baláz P; Valsamis A Cas Lek Cesk; 2010; 149(4):160-2. PubMed ID: 20518248 [TBL] [Abstract][Full Text] [Related]
8. Plasma citrulline concentration as a biomarker for bowel loss and adaptation in hospitalized pediatric patients requiring parenteral nutrition. Stultz JS; Tillman EM; Helms RA Nutr Clin Pract; 2011 Dec; 26(6):681-7. PubMed ID: 22205556 [TBL] [Abstract][Full Text] [Related]
9. Specific amino acids in the critically ill patient--exogenous glutamine/arginine: a common denominator? Vermeulen MA; van de Poll MC; Ligthart-Melis GC; Dejong CH; van den Tol MP; Boelens PG; van Leeuwen PA Crit Care Med; 2007 Sep; 35(9 Suppl):S568-76. PubMed ID: 17713411 [TBL] [Abstract][Full Text] [Related]
10. Serum citrulline is a simple quantitative marker for small intestinal enterocytes mass and absorption function in short bowel patients. Jianfeng G; Weiming Z; Ning L; Fangnan L; Li T; Nan L; Jieshou L J Surg Res; 2005 Aug; 127(2):177-82. PubMed ID: 15921697 [TBL] [Abstract][Full Text] [Related]
11. Biomarkers of gut barrier failure in the ICU. Piton G; Capellier G Curr Opin Crit Care; 2016 Apr; 22(2):152-60. PubMed ID: 26808138 [TBL] [Abstract][Full Text] [Related]
12. [Circulating citrulline levels: a biomarker for intestinal functionality assessment]. Crenn P; Hanachi M; Neveux N; Cynober L Ann Biol Clin (Paris); 2011; 69(5):513-21. PubMed ID: 22008130 [TBL] [Abstract][Full Text] [Related]
13. [Plasma citrulline concentration as a biomarker of intestinal function in short bowel syndrome and in intestinal transplant]. Vecino López R; Andrés Moreno AM; Ramos Boluda E; Martinez-Ojinaga Nodal E; Hernanz Macías A; Prieto Bozano G; Lopez Santamaria M; Tovar Larrucea JA An Pediatr (Barc); 2013 Oct; 79(4):218-23. PubMed ID: 23528708 [TBL] [Abstract][Full Text] [Related]
14. Catecholamine use is associated with enterocyte damage in critically ill patients. Piton G; Cypriani B; Regnard J; Patry C; Puyraveau M; Capellier G Shock; 2015 May; 43(5):437-42. PubMed ID: 25565647 [TBL] [Abstract][Full Text] [Related]
15. Citrulline and the gut. Curis E; Crenn P; Cynober L Curr Opin Clin Nutr Metab Care; 2007 Sep; 10(5):620-6. PubMed ID: 17693747 [TBL] [Abstract][Full Text] [Related]
16. Gut dysfunction in critically ill patients: a review of the literature. Stechmiller JK; Treloar D; Allen N Am J Crit Care; 1997 May; 6(3):204-9. PubMed ID: 9131199 [TBL] [Abstract][Full Text] [Related]
17. Citrulline blood levels as indicators of residual intestinal absorption in patients with short bowel syndrome. Santarpia L; Catanzano F; Ruoppolo M; Alfonsi L; Vitale DF; Pecce R; Pasanisi F; Contaldo F; Salvatore F Ann Nutr Metab; 2008; 53(2):137-42. PubMed ID: 18997462 [TBL] [Abstract][Full Text] [Related]
18. Plasma citrulline level as a biomarker for cancer therapy-induced small bowel mucosal damage. Barzał JA; Szczylik C; Rzepecki P; Jaworska M; Anuszewska E Acta Biochim Pol; 2014; 61(4):615-31. PubMed ID: 25473654 [TBL] [Abstract][Full Text] [Related]
19. Impairment of arginine metabolism in rats after massive intestinal resection: effect of parenteral nutrition supplemented with citrulline compared with arginine. Osowska S; Neveux N; Nakib S; Lasserre V; Cynober L; Moinard C Clin Sci (Lond); 2008 Sep; 115(5):159-66. PubMed ID: 18186708 [TBL] [Abstract][Full Text] [Related]
20. Plasma citrulline as a quantitative biomarker of HIV-associated villous atrophy in a tropical enteropathy population. Papadia C; Kelly P; Caini S; Corazza GR; Shawa T; Franzè A; Forbes A; Di Sabatino A Clin Nutr; 2010 Dec; 29(6):795-800. PubMed ID: 20646802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]